Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.
Saved in:
| Title: | Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial. |
|---|---|
| Authors: | Gálvez NMS; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Pacheco GA; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Schultz BM; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Melo-González F; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.; Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, Chile., Soto JA; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.; Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, Chile., Duarte LF; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., González LA; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Rivera-Pérez D; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Ríos M; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Berrios RV; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Vázquez Y; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Moreno-Tapia D; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Vallejos OP; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Andrade CA; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Hoppe-Elsholz G; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Iturriaga C; Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile., Urzua M; Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile., Navarrete MS; Centro de Investigación Clínica UC, Pontificia Universidad Católica de Chile, Santiago, Chile., Rojas Á; Departamento de Enfermedades Infecciosas del Adulto, División de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile., Fasce R; Departamento de Laboratorio Biomédico, Instituto de Salud Pública de Chile, Santiago, Chile., Fernández J; Departamento de Laboratorio Biomédico, Instituto de Salud Pública de Chile, Santiago, Chile., Mora J; Departamento de Laboratorio Biomédico, Instituto de Salud Pública de Chile, Santiago, Chile., Ramírez E; Departamento de Laboratorio Biomédico, Instituto de Salud Pública de Chile, Santiago, Chile., Gaete-Argel A; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile., Acevedo ML; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile., Valiente-Echeverría F; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile., Soto-Rifo R; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile., Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, United States., Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, United States., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, United States.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, United States., Zeng G; Sinovac Biotech, Beijing, China., Meng W; Sinovac Life Sciences Co., Ltd., Beijing, China., González-Aramundiz JV; Departamento de Farmacia, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile., Johnson M; Department of Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Goldblatt D; Department of Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., González PA; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Abarca K; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile., Bueno SM; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Kalergis AM; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.; Departamento de Endocrinología, Facultad de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. |
| Corporate Authors: | CoronaVacCL03 Study Group |
| Source: | ELife [Elife] 2022 Oct 13; Vol. 11. Date of Electronic Publication: 2022 Oct 13. |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36226829 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gálvez+NMS%22">Gálvez NMS</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Pacheco+GA%22">Pacheco GA</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Schultz+BM%22">Schultz BM</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Melo-González+F%22">Melo-González F</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.; Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Soto+JA%22">Soto JA</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.; Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Duarte+LF%22">Duarte LF</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22González+LA%22">González LA</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Rivera-Pérez+D%22">Rivera-Pérez D</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Ríos+M%22">Ríos M</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Berrios+RV%22">Berrios RV</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Vázquez+Y%22">Vázquez Y</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Moreno-Tapia+D%22">Moreno-Tapia D</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Vallejos+OP%22">Vallejos OP</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Andrade+CA%22">Andrade CA</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Hoppe-Elsholz+G%22">Hoppe-Elsholz G</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Iturriaga+C%22">Iturriaga C</searchLink>; Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Urzua+M%22">Urzua M</searchLink>; Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Navarrete+MS%22">Navarrete MS</searchLink>; Centro de Investigación Clínica UC, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Rojas+Á%22">Rojas Á</searchLink>; Departamento de Enfermedades Infecciosas del Adulto, División de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Fasce+R%22">Fasce R</searchLink>; Departamento de Laboratorio Biomédico, Instituto de Salud Pública de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Fernández+J%22">Fernández J</searchLink>; Departamento de Laboratorio Biomédico, Instituto de Salud Pública de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Mora+J%22">Mora J</searchLink>; Departamento de Laboratorio Biomédico, Instituto de Salud Pública de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Ramírez+E%22">Ramírez E</searchLink>; Departamento de Laboratorio Biomédico, Instituto de Salud Pública de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Gaete-Argel+A%22">Gaete-Argel A</searchLink>; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Acevedo+ML%22">Acevedo ML</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Valiente-Echeverría+F%22">Valiente-Echeverría F</searchLink>; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Soto-Rifo+R%22">Soto-Rifo R</searchLink>; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Weiskopf+D%22">Weiskopf D</searchLink>; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, United States.<br /><searchLink fieldCode="AU" term="%22Grifoni+A%22">Grifoni A</searchLink>; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, United States.<br /><searchLink fieldCode="AU" term="%22Sette+A%22">Sette A</searchLink>; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, United States.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, United States.<br /><searchLink fieldCode="AU" term="%22Zeng+G%22">Zeng G</searchLink>; Sinovac Biotech, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Meng+W%22">Meng W</searchLink>; Sinovac Life Sciences Co., Ltd., Beijing, China.<br /><searchLink fieldCode="AU" term="%22González-Aramundiz+JV%22">González-Aramundiz JV</searchLink>; Departamento de Farmacia, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Johnson+M%22">Johnson M</searchLink>; Department of Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Goldblatt+D%22">Goldblatt D</searchLink>; Department of Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22González+PA%22">González PA</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Abarca+K%22">Abarca K</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Bueno+SM%22">Bueno SM</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Kalergis+AM%22">Kalergis AM</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.; Departamento de Endocrinología, Facultad de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22CoronaVacCL03+Study+Group%22">CoronaVacCL03 Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101579614%22">ELife</searchLink> [Elife] 2022 Oct 13; Vol. 11. <i>Date of Electronic Publication: </i>2022 Oct 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22eLife+Sciences+Publications%2C+Ltd%22">eLife Sciences Publications, Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101579614 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-084X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222050084X%22">2050084X </searchLink><i>NLM ISO Abbreviation: </i>Elife <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36226829 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7554/eLife.81477 Languages: – Code: eng Text: English Titles: – TitleFull: Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gálvez NMS – PersonEntity: Name: NameFull: Pacheco GA – PersonEntity: Name: NameFull: Schultz BM – PersonEntity: Name: NameFull: Melo-González F – PersonEntity: Name: NameFull: Soto JA – PersonEntity: Name: NameFull: Duarte LF – PersonEntity: Name: NameFull: González LA – PersonEntity: Name: NameFull: Rivera-Pérez D – PersonEntity: Name: NameFull: Ríos M – PersonEntity: Name: NameFull: Berrios RV – PersonEntity: Name: NameFull: Vázquez Y – PersonEntity: Name: NameFull: Moreno-Tapia D – PersonEntity: Name: NameFull: Vallejos OP – PersonEntity: Name: NameFull: Andrade CA – PersonEntity: Name: NameFull: Hoppe-Elsholz G – PersonEntity: Name: NameFull: Iturriaga C – PersonEntity: Name: NameFull: Urzua M – PersonEntity: Name: NameFull: Navarrete MS – PersonEntity: Name: NameFull: Rojas Á – PersonEntity: Name: NameFull: Fasce R – PersonEntity: Name: NameFull: Fernández J – PersonEntity: Name: NameFull: Mora J – PersonEntity: Name: NameFull: Ramírez E – PersonEntity: Name: NameFull: Gaete-Argel A – PersonEntity: Name: NameFull: Acevedo ML – PersonEntity: Name: NameFull: Valiente-Echeverría F – PersonEntity: Name: NameFull: Soto-Rifo R – PersonEntity: Name: NameFull: Weiskopf D – PersonEntity: Name: NameFull: Grifoni A – PersonEntity: Name: NameFull: Sette A – PersonEntity: Name: NameFull: Zeng G – PersonEntity: Name: NameFull: Meng W – PersonEntity: Name: NameFull: González-Aramundiz JV – PersonEntity: Name: NameFull: Johnson M – PersonEntity: Name: NameFull: Goldblatt D – PersonEntity: Name: NameFull: González PA – PersonEntity: Name: NameFull: Abarca K – PersonEntity: Name: NameFull: Bueno SM – PersonEntity: Name: NameFull: Kalergis AM IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 10 Text: 2022 Oct 13 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2050-084X Numbering: – Type: volume Value: 11 Titles: – TitleFull: ELife Type: main |
| ResultId | 1 |
